Life Stem Genetics Inc.
Life Stem Genetics Inc.
Your view on LIFS
Overview
What the company does, where it operates, and who runs it.
About Life Stem Genetics Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Gloria Simov
- Headquarters
- 3300 Parker Lane, East Stroudsburg, NV, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Gloria Simov
- Headquarters
- 3300 Parker Lane, East Stroudsburg, NV, US
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide.
Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation.
The company was founded in 2012 and is based in Beverly Hills, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Life Stem Genetics Inc., and the rating behind it. LIFS last traded at $0.0002; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Life Stem Genetics Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Life Stem Genetics Inc.. Life Stem Genetics Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Life Stem Genetics Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Life Stem Genetics Inc.. Life Stem Genetics Inc. has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Life Stem Genetics Inc. valued side by side against its closest peers. Life Stem Genetics Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Life Stem Genetics Inc., and how their positions are changing. At a $9,168 market value, institutional positions materially move Life Stem Genetics Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Life Stem Genetics Inc. executives and directors. Shares of Life Stem Genetics Inc. have traded between $0.0001 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Life Stem Genetics Inc.. Life Stem Genetics Inc. is a $9,168 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Life Stem Genetics Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Life Stem Genetics Inc.. Coverage tracks Life Stem Genetics Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.